Meclofenamate does not affect lung development in fetal sheep.
Prostaglandins may be involved in some aspects of fetal lung development, including surfactant metabolism, tracheal fluid production, and possibly lung growth. In the fetus, during the days before delivery, plasma PGE2 concentration increases and concurrently, tracheal fluid production decreases and surfactant production increases. To determine whether the increase in PGE2, specifically plasma PGE2 concentration, is responsible for these changes, we continuously infused the prostaglandin synthetase inhibitor, meclofenamate (0.7 mg/h per kg), into 8 fetal sheep for 5-13 days before delivery; 5 control fetuses received a continuous infusion of solvent for 5-11 days before delivery. Meclofenamate infusion significantly decreased plasma PGE2 concentrations until the day of delivery. However, meclofenamate did not affect tracheal fluid production or its decrease before delivery, fetal plasma cortisol concentration, surfactant content of tracheal fluid and lung tissue, organ weights, lung weights, or lung DNA and protein content. We conclude that the changes in lung development during the days before delivery are not dependent on the usual high fetal plasma concentration of PGE2 or its increase before delivery.
Wallen
L D
LD
Cardiovascular Research Institute, San Francisco, California.
Murai
D T
DT
Clyman
R I
RI
Lee
C H
CH
Mauray
F E
FE
Ballard
P L
PL
Kitterman
J A
JA
D000818:Animals; D015232:Dinoprostone / Q000097:blood / Q000502:physiology*; D005260:Female; D006321:Heart / Q000187:drug effects / Q000254:growth & development; D006854:Hydrocortisone / Q000097:blood; D008168:Lung / Q000187:drug effects / Q000254:growth & development*; D008431:Maternal-Fetal Exchange; D008469:Meclofenamic Acid / Q000494:pharmacology*; D009929:Organ Size; D010713:Phosphatidylcholines / Q000378:metabolism; D011247:Pregnancy; D011663:Pulmonary Surfactants / Q000096:biosynthesis; D012756:Sheep; D062367:ortho-Aminobenzoates / Q000494:pharmacology*
D010713:Phosphatidylcholines; D011663:Pulmonary Surfactants; D062367:ortho-Aminobenzoates; D008469:Meclofenamic Acid; D015232:Dinoprostone; D006854:Hydrocortisone